The Senté Team
Marios Fotiadis – Founder / Board Member, has CEO and venture capital experience in life sciences with SG Capital Partners and Advent International. He currently serves as President & CEO of the Vandell Group.
Faheem Hasnain – Chairman of the Board, has over 20 years experience in the pharmaceuticals industry with extensive commercialization experience in senior management roles. He is currently President and Chief Executive Officer of Receptos, Inc. and the previous President and CEO of Facet Biotech, which sold to Abbot Laboratories for over $700M in March of 2010. He has launched more than 20 new products in more than 30 indications with line extensions across 12 therapeutic areas. He has previously served in executive roles with Biogen Idec; Oncology Therapeutics Network (OTN), a specialty pharmacy distributor and subsidiary to Bristol-Myers Squibb Company; and GlaxoSmithKline where he held numerous roles including Commercial and Vice President, Dermatology business.
Magda Marquet, Ph.D. – Board Member, Dr. Marquet is the founder and co-Chair of Ajinomoto Althea Technologies, and served as its co-President and CEO for ten years. Dr. Marquet is also founder and co-Chair of Althea Dx, a spin-off of Althea Technologies focusing in companion diagnostics development. She is the Chairwoman of BIOCOM and she is on the Board of UCSD Moores Cancer Center. She is currently involved as investor, adviser, and board member in over twenty local San Diego companies. Dr. Marquet has over twenty-five years of experience in the biotechnology industry in the United States and Europe. She was formerly Executive Director of Pharmaceutical Development at Vical Incorporated, where she patented several novel methods for the production of clinical grade DNA for use in gene therapy and DNA vaccines. Prior to joining Vical, Dr. Marquet held management positions at Amylin Pharmaceuticals, Protein Polymer Technologies, Syntro Corporation and Transgene. Dr. Marquet holds a Ph.D. in Biochemical Engineering from INSA/University of Toulouse, France. Dr. Marquet was the winner of the 2005 Regional Ernst & Young Entrepreneur of the Year award in the Life Sciences category.
Michael York – President & Chief Executive Officer, Mr. York brings to Sente more than 20 years of management, commercial and finance experience in the biopharmaceutical industry, including leadership positions in sales, marketing, pricing, managed care, commercial operations, and investor relations at early stage and global life sciences companies.
Most recently, Michael was Vice President, Sales and Marketing for the Specialty and Rare Disease Business Unit at Amylin Pharmaceuticals where he was responsible for leading worldwide development and commercialization of Amylin products and pipeline assets in the endocrine specialty market. Prior to this role, Michael served as Senior Director of Investor Relations at Amylin and held responsibility for managing the financial global brand. Michael has significant experience in developing relationships with U.S. and European equity analysts and investment bankers along with attracting and retaining long-term investors, including mutual funds and hedge funds. Michael holds a BA degree in Public Administration and Economics from San Diego State University and a MBA degree from the University of Redlands.
Randy Kriech – Chief Commercial Officer, brings to Senté nearly 20 years of management and commercial experience in the dermatology industry with more than 13 years focused on the development and marketing of aesthetic skincare products. He has held a wide range of leadership positions in sales, marketing and business development. He leads global marketing strategy, commercial operations and product portfolio development.
Most recently, Randy was Vice President of Sales and Marketing at PrecisionMD, the aesthetic division of Precision Dermatology, where he was responsible for leading worldwide commercialization of the PrecisionMD portfolio. He has held management roles with a number of companies during their start-up phase within the dermatology marketplace including SkinMedica and Celfix Cosmeceuticals in which he was Co-Founder and Owner. Randy holds a Bachelor of Arts degree in Communications from the University of Colorado, Boulder.
Michael Brower – Chief Financial Officer, Michael has over 25 years of experience in senior financial and operational roles primarily in the consumer products markets. Most recently, Michael served as Chief Financial and Operations Officer at LifeSaver, a San Diego based company developing innovative and patent pending saliva diagnostic testing. Prior to LifeSaver, he served as Chief Financial and Operations Officer at Gunar Optiks, a leader in computer technology eyewear and was recognized as one of San Diego’s 100 fastest growing private companies. Additionally, he served on the executive team at leading brands Spy Optic and Odyssey Golf, where he played a key role in each of their successful exits. Earlier in his career he was a staff accountant with KPMG LLP where he earned his CPA license. He received a Bachelor Degree from Chico State, and earned an MBA from the University of San Diego.
Aaron Hasnain – Manager of Account Relations & Director of New Media
Mireille Gillings – Board Member, Dr. Gillings is the founder, President, CEO and Executive Chair of HUYA Bioscience, a privately-held company and global leader in accelerating the co-development of novel biopharmaceutical product opportunities originating in China. Dr. Gillings was the first to establish extensive collaborations with Chinese academic and commercial biopharmaceutical organisations to speed the development and value creation in worldwide markets for China-sourced novel biopharmaceutical compounds.
Dr. Gillings has 20 years experience in the biotechnology industry including drug development and pre-clinical study design. She has made significant contributions to research in the field of neurological disease, focusing on neuroactive steroids and neurological and neurodegenerative diseases.
Dr. Gillings completed post-doctoral fellowships at Bordeaux University and Scripps Research Institute and holds a Ph.D. from Radboud University Nijmegen. She is the vice chair and co-founder GHO Capital, a private equity fund specialising in global health; serves on the board of Quintiles, a Fortune 500 company, where she is a member of the Governance, Quality and Nominating Committee; and serves on the Pasteur Institute Advisory Board. Dr. Gillings speaks Dutch, French, English and Spanish.
To explore career opportunities with Senté, please visit our
careers page by clicking here.